Amer, Marwa
Al-Dorzi, Hasan M.
Aldekhyl, Sara
Al Qahtani, Saad
Lewis, Kimberley
Abdukahil, Sheryl Ann
Altamimi, Abdullah M.
Alanazi, Samiyah Alrawy
AlObaidi, Mohammed
Alswaidan, Lolowa M.
Al Harbi, Mohammed Khulaif
Al Qasim, Eman
Kharaba, Ayman
Albrahim, Talal
Alshahrani, Mohammed S.
Al-Fares, Abdulrahman A.
Al Bshabshe, Ali
Mady, Ahmed
Al Duhailib, Zainab
Algethamy, Haifa
Jose, Jesna
Al Mutairi, Mohammed
Al Zumai, Omar
Al Haji, Hussain
Alaqeily, Ahmed
Al Aseri, Zohair
Al-Omari, Awad
Al-Dawood, Abdulaziz
Tlayjeh, Haytham
Arabi, Yaseen M. https://orcid.org/0000-0001-5735-6241
Clinical trials referenced in this document:
Documents that mention this clinical trial
Helmet Non-Invasive Ventilation for COVID-19 Patients (Helmet-COVID): study protocol for a multicentre randomised controlled trial
https://doi.org/10.1136/bmjopen-2021-052169
Dexmedetomidine for sedation during noninvasive ventilation in COVID-19 patients from the Helmet-COVID randomized clinical trial post-hoc analysis
https://doi.org/10.1038/s41598-026-49301-9
Long-term outcomes of patients with COVID-19 treated with helmet noninvasive ventilation or usual respiratory support: follow-up study of the Helmet-COVID randomized clinical trial
https://doi.org/10.1007/s00134-023-06981-5
Article History
Received: 21 September 2024
Accepted: 14 April 2026
First Online: 9 May 2026
Competing interests
: The authors declare no competing interests.
: The Institutional Review Boards of all participating centers approved HELMET-COVID trial including King Abdullah International Medical Research center, Riyadh, Saudi Arabia; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia; King Fahad Hospital of the University, Imam Abdulrahman Bin Faisal University, Al Khobar, Saudi Arabia; Al-Amiri Hospital, Ministry of Health, Kuwait; King Abdulaziz University Hospital, Jeddah, Saudi Arabia; King Khalid University/Aseer Central Hospital, Abha, Saudi Arabia; King Saud University, Riyadh, Saudi Arabia; King Saud Medical City, Riyadh, Saudi Arabia; and Dr Sulaiman Al Habib Medical Group, Riyadh, Saudi Arabia . Informed consent was obtained from all enrolled patients or their surrogate decision-makers.